Interleukin–33, Oxidative Stress in Prediabetic Polycystic Ovary Syndrome Patients with Insulin Resistance
Background: Polycystic ovary syndrome (PCOS) is one of the common female endocrine disorders of uncertain etiology, which causes menstrual disorders as well as infertility. Interleukin–33(IL-33) is considered as a strong risk marker of inflammation and may have possible role in pathogenesis of PCOS....
Main Authors: | Wafa F. Al-Taie, Zainab M. AL-Rubaei, Abeer Jabbar Hassan |
---|---|
Format: | Article |
Language: | English |
Published: |
College of Medicine University of Baghdad
2014-04-01
|
Series: | مجلة كلية الطب |
Subjects: | |
Online Access: | http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/443 |
Similar Items
-
The Pro-inflammatory IL6 and serum glucose in Polycystic Ovary Syndrome
by: Hayfaa S. AL-Hadithi, et al.
Published: (2013-07-01) -
Total L-carnitine and insulin resistance in non-obese and obese Iraqi women with polycystic ovary syndrome
by: Maad M. Shallal, et al.
Published: (2023-04-01) -
Total L-carnitine and insulin resistance in non-obese and obese Iraqi women with polycystic ovary syndrome
by: Maad M. Shallal, et al.
Published: (2023-04-01) -
Effect of pioglitazone treatment on serum chemerin and vaspin levels in polycystic ovary syndrome.
by: Rana Hussein Kutaif, et al.
Published: (2022-04-01) -
The latest reports and treatment methods on polycystic ovary syndrome
by: Natalia Anna Stańczak, et al.
Published: (2024-12-01)